Medicine Data for Secondary Uses
The Medicine Data for Secondary Uses workstream aims to collect data about the use of medicines by NHS care providers in England and make it available to approved organisations for research, analysis and planning purposes. Our ambition is this will produce evidence that can be used to improve NHS health and care services.
The Secondary Care ePMA Data Collection
In May 2024 we published documentation to enable us to collect medicine data weekly from each hospital in England with an electronic prescribing and medicines administration system (ePMA). This is to create a collection of information about medicines that have been prescribed and given to patients; whilst in hospital, when being discharged back to the care of their GP, and when they are being treated as outpatients.
The collection will initially be from the hospital’s main ePMA system that covers most of their wards. Many hospitals have more than one ePMA system, with different systems being used for specialities such as cancer, dialysis, intensive care, maternity, and ophthalmology. We will consider how we could collect data from the speciality ePMA systems in the future.
Organisations who can seek access to the data
Organisations that want to access the data are required to seek approval by completing NHS England’s Data Access Request Service process, which examines:
- why the organisation wants access
- what the benefits will be (there must be a benefit to health and/or social care)
- that cyber security and restricted access mechanisms are in place
- if a suitable Data Sharing Agreement or Data Sharing Framework Contract is in place
All organisations will need to use Secure Data Environments to access the data. NHS England takes its responsibility to safeguard patient data extremely seriously and data shared by us is subject to strict rules around privacy, security and confidentiality.
Data collection will start on 13 January 2025, with the data being available for analysis and research from that date.
We will retrospectively collect older data from June 2018, which increases the usefulness of the data for analysis, as it covers the period before, during and after the COVID-19 pandemic, and also matches the date ranges for medicine data collected for primary care dispensing.
Benefits
- make prescribing safer for patients by improving understanding of why some people experience complications or side effects caused by taking a mixture of medicines
- provide more evidence of the effectiveness of medicines at treating specific illnesses such as improving our knowledge of the benefits and risks of new medicines
- identify areas where overprescribing can be prevented so patients are not given medicines they do not need or want, or where potential harm outweighs the benefit of the medication
- improve the health outcomes of patients by improving understanding of how antibiotics are used and why some conditions are becoming resistant to them
- understand the impact of medicines on the health and care of patients through linkage to other health data
- ensure that patients have equal access to medication, regardless of where they live
- provide information that informs future healthcare plans
- support national strategies relating to medicines use
Medicines dispensed in primary care
In 2019 we established a monthly collection from the NHS Business Services Authority (NHSBSA) of patient-level data about medicines dispensed and claimed for in community settings (predominantly community pharmacy).
This provides information about what medicines are dispensed in primary care by a community or internet pharmacy. The collection is ongoing. Find out more about Medicines dispensed in Primary Care NHS Business Services Authority data.
Medicines prescribed in hospitals and available for COVID-19 research and analysis
Between 2020 and 2023 we collected data from the main ePMA (electronic Prescribing and Medicines Administration) systems of 26 NHS hospital trusts in England. This was to support the UK’s COVID-19 response. Data was collected each week from December 2020 to August 2023, with an additional historical collection from January 2019 to December 2020 to provide a full year of pre-pandemic data.
The collection stopped in August 2023, but the data remains available for research and analysis through NHS England’s Data Access Request Service. It contains 91.9 million prescriptions and 466.6 million medicine administrations. Find out more information about Electronic Prescribing and Administration (EPMA) Data in Secondary Care under the COVID-19 Directions.
Last edited: 31 May 2024 9:55 am